Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
July 14 2009 - 3:05PM
PR Newswire (US)
CAMBRIDGE, Mass., July 14 /PRNewswire-FirstCall/ -- Idenix
Pharmaceuticals, Inc., (NASDAQ:IDIX) announced today that it will
report its financial results for the second quarter of 2009 on
Monday, July 20, 2009 after U.S. financial markets close. In
conjunction with the issuance of the press release, Idenix
management will host a conference call at 4:30 p.m. ET on Monday,
July 20, 2009 to discuss the company's financial results for the
second quarter of 2009 and provide an update on the company's
discovery and development programs. To access the call please dial
800-774-5358 U.S./Canada or 706-758-9475 International and enter
passcode 20088902 or to listen to a live webcast and view
accompanying slides, go to "Calendar of Events" in the Idenix
Investor Center at http://www.idenix.com/. A replay of the call
will also be available from 6:30 p.m. ET on July 20, 2009 until
August 3, 2009 12:00 a.m. ET. To access the replay, please dial
800-642-1687 U.S./Canada or 706-645-9291 International and enter
passcode 20088902. An archived webcast will also be available for
two weeks after the call on the Idenix website. About Idenix Idenix
Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,
is a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral and other
infectious diseases. Idenix's current focus is on the treatment of
infections caused by the hepatitis C virus. For further information
about Idenix, please refer to http://www.idenix.com/. Amy Sullivan
617-995-9838 (investors) Teri Dahlman 617-995-9905 (media)
DATASOURCE: Idenix Pharmaceuticals, Inc. CONTACT: Investors, Amy
Sullivan, +1-617-995-9838, or Media, Teri Dahlman, +1-617-995-9905,
both of Idenix Pharmaceuticals, Inc. Web Site:
http://www.idenix.com/
Copyright
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals (MM) News Articles